Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2143038 | Lung Cancer | 2009 | 11 Pages |
Abstract
Few issues are as controversial in non-small cell lung cancer as the management of patients with stage IIIA-N2 non-small cell lung cancer. This manuscript reviews the reasons and the biases inherent to this controversy and discusses the different treatment approaches with emphasis on survival as evidenced by meta-analyses and large randomised clinical trials. Prospects on novel treatment modalities and future research opportunities are presented.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jan P. van Meerbeeck, Veerle F.M. Surmont,